Delivery Order SPE2DB20D3103-SPE2DB22FP4L5

Award Date 8/9/22
Potential Completion Date 8/10/22
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,310.26, is for the delivery of Sirolimus 0.5 mg tablets. It is a firm fixed-price, delivery order contract with an ultimate completion date of April 18, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization registered in...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,491.30, is for the delivery of Sirolimus 0.5 mg tablets. The contract has an ultimate completion date of April 8, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 tablets of the pharmaceutical product SIROLIMUS 2 MG. The $2,080.06 order has a completion date of December 22, 2023 and was placed without the use of a set-aside. Amerisourcebergen Drug Corp, through its Corporate Office division, has extensive experience as a prime contractor supplying pharmaceuticals, medical...
This is a $4,196.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. AmerisourceBergen was awarded the delivery order to provide Sirolimus 1 mg/ml solution, a pharmaceutical product, to support military treatment programs and facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen, valued up to $999,999,999.00...
This federal contract award, with ID SPE2DB24D2105|SPE2DB25FAPGP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,483.99 firm fixed-price delivery order is for the supply of 4567361943 - SIROLIMUS 0.5 MG TABLET 100S. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 24, 2025. This contract is not designated as a set-aside. Amerisourcebergen...
The federal contract award is for the delivery of Sirolimus 1 mg tablets to the Defense Logistics Agency (DLA) under contract number SPE2DB20D3103|SPE2DB22FM0P7. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,959.29 and an ultimate completion date of December 22, 2021. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award, valued at $1,315.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Sirolimus 1 mg tablets, a pharmaceutical product used in various medical treatments. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This IDC serves...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,842.64 firm-fixed-price delivery order is for the supply of Everolimus 0.5 mg tablets. The contract has an ultimate completion date of November 24, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,363.03 firm-fixed-price delivery order is for the supply of 4566998338 Everolimus 0.5 mg tablets, a pharmaceutical product used in various medical treatments. The contract has a completion date of January 22, 2025 and was awarded on January 21, 2025. No set-aside designation was used for this contract....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Everolimus 0.5 mg tablets, a medication used for various medical conditions. The contract has a firm fixed price of $15,880.66 and a completion date of September 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP4L5
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.60 contract is for the delivery of SIROLIMUS 0.5 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of August 10, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:14 PM